West Health



Reducing Emergency Department Transfers from Skilled Nursing Facilities through an Emergency Physician Telemedicine Service

Transfers of skilled nursing facility (SNF) residents to emergency departments (ED) are linked to morbidity, mortality and significant cost, especially when transfers result in hospital admissions. This study investigated an alternative approach for emergency care delivery comprised of SNF-based telemedicine services provided by emergency physicians (EP). We compared this on-site emergency care option to traditional ED-based care, evaluating hospital admission rates following care by an EP.

Emergency Medical Technician-Facilitated Telehealth Visits: A New Model to Expand Home-Based Primary Care for Homebound Seniors

August 7, 2020 Authors: Karen A. Abrashkin1, A. Camille McBride1, Jill C. Slaboda 2, Michael Kurliand 2, Amparo Abel-Bey 1, Atika Turkistani 1, Kayla Finuf 1, Renee Pekmazaris 1 Affiliations: 1Northwell Health, New Hyde Park, NY, USA; 2West Health, La Jolla, CA, USA Objective: As the number of older adults living in the United States… Read more »

Launching an Emergency Department Telehealth Program During COVID-19: Real-World Implementations for Older Adults

The Office of the National Coordinator for Health Information Technology (ONC), broadly defines telehealth as the use of electronic information and technologies to support and promote long-distance clinical care, patient and professional health-related education, public health and health administration. Forward triage is the sorting of patients based on needs before potential ED transfer. Forward triage establishes who requires ED treatment, prioritizes care delivery, and determines appropriateness of treatment in place, or in other settings.2 This paper highlights different models of how telehealth is being deployed by ED’s around the country based on needs, clinical setting, and resources.

West Health Policy Center Commissioned Analysis

Proposed changes to the Medicare Part D benefit design have significant financial implications for all Part D stakeholders, including the federal government, Part D beneficiaries, and pharmaceutical manufacturers.